美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=QTERN"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
QTERN 209091 001 NDA DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE TABLET;ORAL 10MG;EQ 5MG BASE Yes Yes 2017/02/27 2017/02/27 ASTRAZENECA AB Prescription
QTERN 209091 002 NDA DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE TABLET;ORAL 5MG;EQ 5MG BASE Yes No 2017/02/27 2019/05/02 ASTRAZENECA AB Prescription
QTERNMET XR 210874 001 NDA DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 2.5MG;1GM;EQ 2.5MG BASE Yes No 2019/05/02 2019/05/02 ASTRAZENECA AB Discontinued
QTERNMET XR 210874 002 NDA DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 5MG;1GM;EQ 2.5MG BASE Yes No 2019/05/02 2019/05/02 ASTRAZENECA AB Discontinued
QTERNMET XR 210874 003 NDA DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 5MG;1GM;EQ 5MG BASE Yes No 2019/05/02 2019/05/02 ASTRAZENECA AB Discontinued
QTERNMET XR 210874 004 NDA DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 10MG;1GM;EQ 5MG BASE Yes No 2019/05/02 2019/05/02 ASTRAZENECA AB Discontinued
药品名称,活性成分,申请号搜索 高级检索
©2006-2022 DrugFuture->U.S. FDA Drugs Database